Cargando…

The UBE2C/CDH1/DEPTOR axis is an oncogene and tumor suppressor cascade in lung cancer cells

Ubiquitin-conjugating enzyme E2C (UBE2C) mediates ubiquitylation chain formation via the K11 linkage. While previous in vitro studies showed that UBE2C plays a growth-promoting role in cancer cell lines, the underlying mechanism remains elusive. Still unknown is whether and how UBE2C plays a promoti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Shizhen, You, Xiahong, Zheng, Yawen, Shen, Yanwen, Xiong, Xiufang, Sun, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927933/ https://www.ncbi.nlm.nih.gov/pubmed/36548081 http://dx.doi.org/10.1172/JCI162434

Ejemplares similares

DEPTOR is an in vivo tumor suppressor that inhibits prostate tumorigenesis via the inactivation of mTORC1/2 signals
por: Chen, Xiaoyu, et al.
Publicado: (2019)

Ribosomal protein S27-like regulates autophagy via the β-TrCP-DEPTOR-mTORC1 axis
por: Xiong, Xiufang, et al.
Publicado: (2018)

A small molecule inhibitor of the UBE2F-CRL5 axis induces apoptosis and radiosensitization in lung cancer
por: Xu, Tiantian, et al.
Publicado: (2022)

DEPTOR is a direct p53 target that suppresses cell growth and chemosensitivity
por: Cui, Danrui, et al.
Publicado: (2020)

Nuclear ErbB2 represses DEPTOR transcription to inhibit autophagy in breast cancer cells
por: Bi, Yanli, et al.
Publicado: (2021)

DEPTOR in Skeletal Development and Diseases
por: Perez-Tejeiro, Jose Miguel, et al.
Publicado: (2021)

PD-L1 induction via the MEK-JNK-AP1 axis by a neddylation inhibitor promotes cancer-associated immunosuppression
por: Zhang, Shizhen, et al.
Publicado: (2022)

Elucidating the role of DEPTOR in Alzheimer’s disease
por: DAVIES, JULIE, et al.
Publicado: (2014)

DEPTOR stabilizes ErbB2 to promote the proliferation and survival of ErbB2-positive breast cancer cells
por: Bi, Yanli, et al.
Publicado: (2021)

Deptor: not only a mTOR inhibitor
por: Catena, Valeria, et al.
Publicado: (2017)

Regulation of human mTOR complexes by DEPTOR
por: Wälchli, Matthias, et al.
Publicado: (2021)

Function of Deptor and its roles in hematological malignancies
por: Morales-Martinez, Mario, et al.
Publicado: (2021)

Cdh1 functions as an oncogene by inducing self-renewal of lung cancer stem-like cells via oncogenic pathways
por: Ye, Ting, et al.
Publicado: (2020)

Placental DEPTOR as a stress sensor during pregnancy
por: Mparmpakas, Dionisis, et al.
Publicado: (2011)

Loss of hepatic DEPTOR alters the metabolic transition to fasting
por: Caron, Alexandre, et al.
Publicado: (2017)

miRNA‐182/Deptor/mTOR axis regulates autophagy to reduce intestinal ischaemia/reperfusion injury
por: Li, Yunsheng, et al.
Publicado: (2020)

Tumor-Suppressor Genes and Oncogenes
Publicado: (1993)

Oncogenes and tumor-suppressor genes.
por: Lehman, T A, et al.
Publicado: (1991)

Neddylation inhibition ameliorates steatosis in NAFLD by boosting hepatic fatty acid oxidation via the DEPTOR-mTOR axis
por: Serrano-Maciá, Marina, et al.
Publicado: (2021)

Insights into the ISG15 transfer cascade by the UBE1L activating enzyme
por: Wallace, Iona, et al.
Publicado: (2023)

Angiomotin Family Members: Oncogenes or Tumor Suppressors?
por: Lv, Meng, et al.
Publicado: (2017)

Loss of DEPTOR in renal tubules protects against cisplatin-induced acute kidney injury
por: Wang, Caixia, et al.
Publicado: (2018)

Elevated expression of UBE2T exhibits oncogenic properties in human prostate cancer
por: Wen, Mingxin, et al.
Publicado: (2015)

RUNX family: Oncogenes or tumor suppressors
por: Otálora-Otálora, Beatriz Andrea, et al.
Publicado: (2019)

PUM1 Promotes Tumor Progression by Activating DEPTOR‐Meditated Glycolysis in Gastric Cancer
por: Yin, Songcheng, et al.
Publicado: (2023)

DEPTOR has growth suppression activity against pancreatic cancer cells
por: Li, Hua, et al.
Publicado: (2014)

Deptor transcriptionally regulates endoplasmic reticulum homeostasis in multiple myeloma cells
por: Catena, Valeria, et al.
Publicado: (2016)

Stabilization of DEPTOR sensitizes hypopharyngeal cancer to radiotherapy via targeting degradation
por: Wang, Xuecen, et al.
Publicado: (2022)

Targeting Cullin-RING ligases by MLN4924 induces autophagy via modulating the HIF1-REDD1-TSC1-mTORC1-DEPTOR axis
por: Zhao, Y, et al.
Publicado: (2012)

Enhanced inflammation and attenuated tumor suppressor pathways are associated with oncogene‐induced lung tumors in aged mice
por: Parikh, Neha, et al.
Publicado: (2017)

Double agents: genes with both oncogenic and tumor-suppressor functions
por: Shen, Libing, et al.
Publicado: (2018)

ANGPTL4 functions as an oncogene through regulation of the ETV5/CDH5/AKT/MMP9 axis to promote angiogenesis in ovarian cancer
por: Liu, Yinping, et al.
Publicado: (2022)

High DEPTOR expression correlates with poor prognosis in patients with esophageal squamous cell carcinoma
por: Liu, Nan-bo, et al.
Publicado: (2015)

Cdh11 Acts as a Tumor Suppressor in a Murine Retinoblastoma Model by Facilitating Tumor Cell Death
por: Marchong, Mellone N., et al.
Publicado: (2010)

SIRT3: Oncogene and Tumor Suppressor in Cancer
por: Torrens-Mas, Margalida, et al.
Publicado: (2017)

DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis
por: Ji, Yan-Mei, et al.
Publicado: (2016)

Prognostic and clinicopathological significance of DEPTOR expression in cancer patients: a meta-analysis
por: Hu, Binwu, et al.
Publicado: (2018)

DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma
por: Quwaider, Dalia, et al.
Publicado: (2017)

System analysis identifies UBE2C as a novel oncogene target for adrenocortical carcinoma
por: Huang, Renlun, et al.
Publicado: (2023)

Major Tumor Suppressor and Oncogenic Non-Coding RNAs: Clinical Relevance in Lung Cancer
por: Inamura, Kentaro
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_72ia4uvf31t91399eeijd5nfd9